Hygeia Healthcare Holdings Co., Limited announced that it repurchased 199,400 ordinary shares on 27 July 2026 via on-market transactions on the Hong Kong Stock Exchange. The shares were bought at prices ranging from HKD 9.95 to HKD 10.05, representing a volume-weighted average cost of HKD 10.02 per share and bringing the total consideration to HKD 2.00 million.

Following the transaction, Hygeia Healthcare’s outstanding share count (excluding treasury shares) declined to 605.65 million, down 0.03% from 605.85 million before the buy-back. Treasury shares rose to 12.85 million. The company’s total issued share capital remains unchanged at 618.50 million shares, as the repurchased stock is being held in treasury rather than cancelled.

The buy-back was executed under the general mandate approved by shareholders on 26 June 2026, which authorises the company to repurchase up to 60.77 million shares. To date, Hygeia Healthcare has repurchased 2.09 million shares under this mandate—equivalent to 0.34% of its issued share base at the mandate date—leaving capacity for a further 58.69 million shares.

In line with Hong Kong listing rules, the company is subject to a moratorium on issuing new shares or disposing of treasury shares until 26 August 2026. All regulatory confirmations required under the Main Board Rules have been provided by the company’s board of directors.